HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel J Levitt Selected Research
Daniel J Levitt Research Topics
Disease
5
Neoplasms (Cancer)
01/2022 - 06/2002
4
Sarcoma (Soft Tissue Sarcoma)
01/2022 - 02/2015
2
Hypersensitivity (Allergy)
01/2022 - 06/2002
2
Febrile Neutropenia
12/2015 - 02/2015
2
Cardiotoxicity
12/2015 - 04/2015
2
Neutropenia
12/2015 - 02/2015
1
Hypertension (High Blood Pressure)
01/2022
1
Breast Neoplasms (Breast Cancer)
01/2022
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2022
1
Headache (Headaches)
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Glioblastoma (Glioblastoma Multiforme)
04/2015
1
Kaposi Sarcoma (Kaposi's Sarcoma)
04/2015
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2015
1
B-Cell Lymphoma (Lymphoma, B Cell)
06/2002
1
Anaphylaxis (Anaphylactic Shock)
06/2002
Drug/Important Bio-Agent (IBA)
3
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2015 - 02/2015
3
DOXO-EMCH
IBA
12/2015 - 02/2015
2
apolizumab
IBA
01/2022 - 06/2002
2
Monoclonal Antibodies
IBA
01/2022 - 06/2002
2
Prodrugs
IBA
12/2015 - 04/2015
1
Antigens
IBA
01/2022
1
HLA-DR Antigens (HLA-DR)
IBA
01/2022
1
Immunoglobulin G (IgG)
IBA
01/2022
1
Albumins
IBA
12/2015
1
Serum Albumin
IBA
04/2015
1
adriamycinol
IBA
04/2015
1
Proteins (Proteins, Gene)
FDA Link
06/2002
1
HLA Antigens (Human Leukocyte Antigens)
IBA
06/2002
Therapy/Procedure
1
Therapeutics
12/2015
1
Intravenous Infusions
02/2015